# FDA recall D-1285-2020

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2020-05-22.

## Product

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 5 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0971-02

## Reason for recall

Some bottles may contain mixed strengths of the product.

## Distribution

Nationwide within the United State and Puerto Rico.

## Key facts

- **Recall number:** D-1285-2020
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-22
- **Report date:** 2020-06-10
- **Termination date:** 2021-05-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1285-2020

## Citation

> AI Analytics. FDA recall D-1285-2020. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1285-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*